MAP Pharmaceuticals to Present at Upcoming Investor Conferences
April 28 2011 - 7:00AM
PR Newswire (US)
MOUNTAIN VIEW, Calif.,
April 28, 2011 /PRNewswire/ -- MAP
Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the
Company will participate in the following investor conferences in
May:
Deutsche Bank 36th Annual
Healthcare Conference
|
|
Tuesday, May 3, at 11:20 a.m. ET
in Boston
|
|
|
|
Bank of America Merrill Lynch
Healthcare Conference
|
|
Tuesday, May 10, at 5:00 p.m. PT
in Las Vegas
|
|
|
|
UBS Global Specialty
Pharmaceuticals Conference
|
|
Tuesday, May 24, at 1:00 p.m. BT
in London
|
|
|
A live webcast of each event will be available on the Investor
Relations section of MAP Pharmaceuticals' website at
http://www.mappharma.com. A replay also will be available within 24
hours for seven days following the presentation.
About MAP Pharmaceuticals
MAP Pharmaceuticals is an emerging biopharmaceutical company
focused on developing and commercializing new therapies to address
undermet patient needs in neurology. The Company is developing
LEVADEX, an orally inhaled investigational drug for the acute
treatment of migraine. The Company has reported positive results
from its Phase 3 trial of LEVADEX and has entered into a
collaboration agreement with Allergan, Inc. to co-promote LEVADEX
to neurologists and pain specialists in the U.S. MAP
Pharmaceuticals also applies its proprietary drug particle and
inhalation technologies to generate new pipeline opportunities by
enhancing the therapeutic benefits of proven drugs, while
minimizing risk by capitalizing on their known safety, efficacy and
commercialization history. Additional information about MAP
Pharmaceuticals can be found at http://www.mappharma.com
|
|
CONTACTS:
|
|
|
Lisa Borland
|
|
|
MAP Pharmaceuticals,
Inc.
|
|
|
(650) 386-3122
|
|
|
lborland@mappharma.com
|
|
|
|
|
|
|
SOURCE MAP Pharmaceuticals, Inc.
Copyright 2011 PR Newswire
Map Pharmaceuticals, Inc. (MM) (NASDAQ:MAPP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Map Pharmaceuticals, Inc. (MM) (NASDAQ:MAPP)
Historical Stock Chart
From Jul 2023 to Jul 2024